UNIGE scientists have developed a groundbreaking technology that creates synthetic molecules mimicking antibodies, potentially revolutionizing disease treatments.

New research showed some long COVID patients get symptom relief by taking an extended course of Paxlovid. Data are ...

The antibody targets a stable part of the bird flu virus, ensuring that the immune protection can resist new variants and offer long-term protection against the globally spreading airborne infection.

Certain antiviral and mAb therapies were shown to lower mortality and hospitalization rates in those infected with SARS-CoV-2 Omicron variants.

Few of the many nonpharmacologic efforts to mitigate the spread of COVID-19 in nursing homes during the pandemic were ...

US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

The stock is trading at 1.0150, up 0.6573, gaining 183.7573% on volume of over 422 Million shares, with a day's high of $1.11. The stock announced breaking news on its Monoclonal Antibody designed to ...

A new antibody therapy effectively protects monkeys from severe H5N1 avian flu, offering hope for a universal flu vaccine and ...

PITTSBURGH, Jan. 30, 2025 – A prophylactic antibody-based immune therapy protects ... akin to the SARS-CoV-2 mutants that evolved during the COVID-19 pandemic, and provide lasting protection ...